odanacatib codenamed investigational treatment osteoporosis bone inhibitor cathepsin enzyme involved bone resorption drug developed merck co phase iii clinical trial medicine stopped early review showed highly effective good safety profile merck announced would apply regulatory approval merck discontinued development odanacatib announced would seek regulatory approval analysis discovered increased risk drug developed merck frosst montreal drug article relating musculoskeletal system stub help wikipedia expanding httpsenwikipediaorgwikiodanacatib